Jacob Laubach - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Jacob Laubach

This paper is made freely available by the publisher.

2024 Natalie S. Callander

ORCID

, Rebecca Silbermann, Jonathan L. Kaufman

ORCID

, Kelly N. Godby, Jacob Laubach

ORCID

, Timothy M. Schmidt

ORCID

, Douglas W. Sborov, Eva Medvedova, Brandi Reeves

ORCID

ORCID

, Cesar Rodriguez, Saurabh Chhabra

ORCID

, Ajai Chari, Susan Bal, Larry D. Anderson

ORCID

and 21 other authors

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2021 Alessandra Larocca

ORCID

, Xavier Leleu, Cyrille Touzeau

ORCID

, Joan Bladé, Agne Paner, María‐Victoria Mateos

ORCID

, Michele Cavo, Christopher Maisel, Adrían Alegre, Albert Oriol, Anastasios Raptis, Paula Rodriguez‐Otero

ORCID

, Amitabha Mazumder, Jacob Laubach

ORCID

, Omar Nadeem and 5 other authors

Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Paul G. Richardson

ORCID

, Shaji K. Kumar

ORCID

, Tamás Masszi, Norbert Grzasko

ORCID

, Nizar J. Bahlis

ORCID

, Markus Hansson, Luděk Pour, Irwindeep Sandhu

ORCID

, Peter Ganly, Bartrum W. Baker, Sharon R. Jackson, Anne-Marie Stoppa, Peter Gimsing, Laurent Garderet, Cyrille Touzeau

ORCID

and 7 other authors

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Torben Plesner

ORCID

, Hendrik‐Tobias Arkenau, Francesca Gay

ORCID

, Monique C. Minnema, Mario Boccadoro, Philippe Moreau

ORCID

, Jamie Cavenagh, Aurore Perrot, Jacob P. Laubach

ORCID

, Jakub Krejcik, Tahamtan Ahmadi, Carla de Boer, Diana Chen, Christopher Chiu, Jordan M. Schecter and 1 other authors

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open‐label, phase 1/2 study

Upload

This paper was not found in any repository, but could be made available legally by the author.

2017 Andrew Spencer, Simon Harrison, Jeffrey Zonder, Ashraf Badros, Jacob Laubach

ORCID

, Krystal Bergin, Amit Khot

ORCID

, Todd Zimmerman, Dharminder Chauhan, Nancy Levin, Ann MacLaren

ORCID

, Steven D. Reich, Mohit Trikha, Paul Richardson

ORCID

A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results

Upload

Missing publications? Search for publications with a matching author name.